Perirenal fat as a potential marker and therapeutic target for metabolic syndrome: insights from a multicenter randomized controlled trial.

Front Endocrinol (Lausanne) · 2025 · PMC12140993 · PMID 40487756

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Despite an increasing trend of Scr, LDL-C, FPG, and DBP along with higher PrFV, no significant statistical differences were observed among the groups. 3.2.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.